These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15665627)

  • 21. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
    Mozley PD; Stubbs JB; Plössl K; Dresel SH; Barraclough ED; Alavi A; Araujo LI; Kung HF
    J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
    Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
    J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.
    Burggasser G; Hurtl I; Hauff W; Lukas J; Greifeneder M; Heydari B; Thaler A; Wedrich A; Virgolini I
    J Nucl Med; 2003 Oct; 44(10):1547-55. PubMed ID: 14530465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab'.
    Macfarlane DJ; Smart RC; Tsui WW; Gerometta M; Eisenberg PR; Scott AM
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):648-56. PubMed ID: 16528525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy.
    Van Den Bossche B; Van Belle S; De Winter F; Signore A; Van de Wiele C
    J Nucl Med; 2006 Jan; 47(1):6-13. PubMed ID: 16391181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (99m)Tc-labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization.
    Iznaga-Escobar N; Ramos-Suzarte M; Morales-Morales A; Torres-Arocha L; Rodríguez-Mesa N; Pérez-Rodriguez R
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):687-96. PubMed ID: 15632954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study.
    Decristoforo C; Maina T; Nock B; Gabriel M; Cordopatis P; Moncayo R
    Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1211-9. PubMed ID: 12845487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary radiation dosimetry of a novel PET radiopharmaceutical
    Cheki M; Gali H
    Hell J Nucl Med; 2017; 20(3):241-246. PubMed ID: 29177263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biokinetics and dosimetry analysis in healthy volunteers for a two-injection (rest-stress) protocol of the myocardial perfusion imaging agent technetium 99m-labeled Q3.
    Rohe RC; Thomas SR; Stabin MG; Deutsch EA; Gerson MC; Cummings DD; Maxon HR
    J Nucl Cardiol; 1995; 2(5):395-404. PubMed ID: 9420819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of Tc-99m depreotide (NeoSpect) in axillary sweat glands.
    Danielsson R; Bååth M; Kölbeck KG; Klominek J; Svensson L
    Clin Nucl Med; 2003 Sep; 28(9):789-90. PubMed ID: 12973013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.
    Zanzonico PB; Finn R; Pentlow KS; Erdi Y; Beattie B; Akhurst T; Squire O; Morris M; Scher H; McCarthy T; Welch M; Larson SM; Humm JL
    J Nucl Med; 2004 Nov; 45(11):1966-71. PubMed ID: 15534070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide.
    Cholewinski W; Kowalczyk JR; Stefaniak B; Stefaniak J; Poniatowicz-Frasunek E; Tarkowska A
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):820-4. PubMed ID: 14762697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer.
    Schechter NR; Erwin WD; Yang DJ; Kim EE; Munden RF; Forster K; Taing LC; Cox JD; Macapinlac HA; Podoloff DA
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1583-91. PubMed ID: 19396440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I clinical trial of 99mTc-etarfolatide, an imaging agent for folate receptor in healthy Japanese adults.
    Yamada Y; Nakatani H; Yanaihara H; Omote M
    Ann Nucl Med; 2015 Nov; 29(9):792-8. PubMed ID: 26238440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 99mTc-exendin(9-39)/octreotide: biokinetics and radiation dosimetry in healthy individuals.
    Ocampo-García BE; Santos-Cuevas CL; Luna-Gutiérrez MA; Ignacio-Alvarez E; Pedraza-López M; Manzano-Mayoral C
    Nucl Med Commun; 2017 Nov; 38(11):912-918. PubMed ID: 28953210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodistribution and radiation dosimetry of [11C]DASB in baboons.
    Bélanger MJ; Simpson NR; Wang T; Van Heertum RL; Mann JJ; Parsey RV
    Nucl Med Biol; 2004 Nov; 31(8):1097-102. PubMed ID: 15607492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
    Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
    Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Internal Dosimetry and Biodistribution of 177 Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast Carcinoma.
    Narwadkar YS; Parghane RV; Sahu S; Lad S; Deep K; Wanage G; Suralkar T; Banerjee S; Gupta S; Basu S; Badwe RA
    Clin Nucl Med; 2024 Apr; 49(4):e149-e155. PubMed ID: 38350067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
    Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.